The U.S. Food and Drug Administration on Wednesday authorized the retooled COVID-19 booster shots of both Moderna and Pfizer-BioNTech that target the currently dominant BA.4/BA.5 Omicron variants of the coronavirus.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3